Background and study aim: Hepatocellular carcinoma (HCC) is a hypervascular tumor and its progression is known to be closely related to angiogenesis. Angiopoietin-2 (Ang-2) is one of the angiogenic factors that may have a diagnostic value in HCC. Alpha-fetoprotein (AFP) serum levels are used for screening for HCC with limited success. This study aimed to evaluate diagnostic value in using angiopoietin-2 as a serum marker in HCC patients.
Patients and Methods:
50 patients with HCC (G1), 20 patients with liver cirrhosis (G2), and 20 healthy control persons (G3) were included in this study. Serum AFP and Ang-2 levels were measured by enzyme-linked immunosorbent assay.
Results: Serum Ang-2 levels in the HCC group (1523.54±886.46 pg/ml) was highly significantly elevated as compared to those with cirrhotic liver (222.55±153.60 pg/ml) and controls (138.35±54.09 pg/ml). The Ang-2 levels were significantly different between patients with liver cirrhosis and controls. In HCC patients, the serum Ang-2 levels in patients with portal vein (PV) thrombosis (n=7, 2164.0±960.85 pg/ml) and with large HCC (>5cm in diameter) (n=17, 2017.70±903.06 pg/ml) were significantly higher than those without PV thrombosis (n=43, 1274.47±727.56 pg/ml) and with small HCC (≤5cm in diameter) (n=33, 1268.97±773.93 pg/ml), while the serum AFP levels in patients with portal vein (PV) thrombosis (961.05±1007.70 ng/ml) and with large HCC (>5cm in diameter) (1000.81±1079.57 ng/ml) were not significantly higher than those without PV thrombosis (500.24±733.07 ng/ml) and 
INTRODUCTION

PATIENTS AND METHODS
This study was carried out on 70 patients and 20 controls. An informed consent was obtained before patients enter the study.
They were divided into three groups : Group 1: Included 50 patients with HCC on top of liver cirrhosis. 
RESULTS
There was high statistical significant difference as regard levels of Ang-2 between HCC and cirrhosis patients and controls.There was also high statistical significant difference as regard level of AFP between all groups (Table 1) .
There was high statistical significant difference as regard level of Ang-2 in large sized tumors than small sized one in HCC, while, there was no significant difference between large and small sizes HCC as regard mean value of AFP (Table  2 ).
There was statistical significant difference as regards Ang-2 levels in HCC with portal vein thrombosis than those with patent portal vein ( Table 3 ).
There was no statistical significant difference as regards levels of AFP in HCC with portal vein thrombosis than those with patent portal vein.
ROC analysis displayed 98% sensitivity and 100% specificity for Ang-2 in the discrimination between HCC patients and healthy controls at a cutoff level 315.5pg/L (Table 4) .
Discrimination between cirrhotic and control individuals by Ang-2 serum levels increased somewhat with the progression of cirrhosis. Mean Ang-2 serum levels were significantly different between cirrhotic patients Child C and controls. Mean Ang-2 serum levels were with a high significant difference between patients with HCC in all Child categories, cirrhotic patients and control (Table 4) .
Detection rates have been increased from 64.3% when using AFP alone to 82.9% when using both markers (Table 5 ).
Combined use of AFP and Ang-2 increased the sensitivity to 100% and specificity to 60%. This table shows that, there was highly statistical significant difference as regards level of Ang-2 in large sized tumor than small sized ones in G1, while there was no significant difference between large and small sizes HCC as regard mean value of AFP. When the optimal cutoff level of Ang-2 for discrimination between HCC and cirrhosis (400.5 pg/L) and the established cutoff for AFP (10.78 pg/L) were applied, both markers were elevated in only 55.7% of patients. Either marker alone was elevated in 8.6% (AFP) or 18.6% (Ang-2), whereas 17.1% of HCC patients had normal values for Ang-2 and AFP. Detection rates could have been increased from 64.3% when using AFP alone to 82.9% when using both markers.
Fig. (1) :
Comparison between the three studied groups as regards AFP and Ang-2. This work aimed to study methods which improve the early detection of HCC by measuring serum Ang-2 as well as, AFP to improve the diagnostic ability.
On using the ROC curve to reach the value of the best sensitivity and specificity of AFP; it has been shown that, the sensitivity and specificity of AFP varied with the different cutoff values used. At a cutoff value of 10.78 ng/ml, the sensitivity was 78% and the specificity was 70%. Bruix and Sherman [2] reported the diagnostic cutoff of HCC at 200 ng/ml. In our study, when using this cutoff, the sensitivity declined to 24% while the specificity was 100%. This finding was comparable to that of Oka et al. [19] who reported low sensitivity (13%) and a specificity of 97% at AFP values over 200 ng/ml. When we further increased the cutoff of serum AFP> 400 ng/ml, the specificity increased and the sensitivity decreased to 10% which was close to the results obtained by Rapaccini et al.
[20] who reported a sensitivity of 7.2% at a cutoff > 400 ng/ml.
In this study, AFP was elevated (>200 ng/ml) in only 23 These results are consistent with Scholz et al.
[22] who reported a statistically highly significant elevation of Ang-2 serum levels in cirrhosis patients when compared to control persons. Although, there are few data available regarding the expression of angiopoietins in cirrhosis in humans, many theories could be speculated in explanation:
Ang-2 is released in inflammatory conditions such as, chronic HCV infection (22). Salcedo et al. [23] reported that, chronic HCV patients showed elevated serum baseline VEGF and Ang-2 levels. After treatment by interferon alpha 2b plus ribavirin, both factors were decreased, whereas, antiangiogenic Tie-2 was increased, indicating a shift toward an "anti-angiogenic" profile of serum markers in chronic HCV patients.
These data may argue against inflammation as the sole reason for elevated Ang-2 levels in serum of cirrhotic patients and emerge the fibrosis process as an extra explanation [22]. Other similar findings include generation of neo-vessels in primary biliary cirrhosis patients accompanied by the increased expression of VEGF, Ang-2 and Tie-2 [24]. Taken together, these published data suggest a causative role of angiogenic factors such as Ang-2, in the remodeling of the cirrhotic liver.
ROC analysis displayed 98% sensitivity and 100% specificity for the discrimination between HCC patients and healthy controls at a cutoff level of 315.5pg/L (AUC 0.99).
ROC analysis revealed that, Ang-2 levels discriminated with 98% sensitivity and 85% specificity between patients with HCC and cirrhotic patients at a cutoff level of 400.5pg/L (AUC 0.98).
These results are consistent with Scholz et al.
[22] who reported a sensitivity of 70.56% and specificity of 73.28% when the high cutoff value of Ang-2 was used (12350pg/ml), the sensitivity and specificity were 40% and 100% respectively. These results demonstrate that the high cutoff value of serum Ang-2 may show better results of specificity than the best cutoff value of (315.5 pg/ml) at the expense of much decrease of sensitivity value.
This study revealed a significantly higher Ang-2 level in combined HBV&HCV induced HCC than HCV and HBV alone. In our results, the combined use of the two markers (AFP and Ang-2) led to an increase in the sensitivity of AFP from 64.3% to 83%. These results were in agreement with Scholz et al.
[22] who compared the ability of Ang-2 serum levels to predict HCC with elevated AFP in patients with established HCC and in patients with cirrhosis but without HCC. Whereas, both markers were elevated in 50% of patients, either one of the markers alone was elevated in 18.6% and 8.6% of patients, respectively. Scholz et al.
[22] concluded that, detection rates could increase from 64.3% when using AFP alone to 82.9% when using both markers.
CONCLUSION:
From this study, it was concluded that combined measurement of serum AFP and Ang-2 significantly increases the sensitivity, and specificity in detection of HCC in cirrhotic patients rather than using of AFP or Ang-2 separately. Ang-2 may be a helpful tool in the diagnosis of vascular invasion in patients with HCC, as it was significantly elevated in HCC patients with portal vein thrombosis when compared to those without.
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